Skip to content

Imaging Biomarkers of Knee Osteoarthritis

Imaging Biomarkers of Knee Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02888119
Enrollment
50
Registered
2016-09-02
Start date
2016-07-31
Completion date
2021-12-13
Last updated
2022-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

This study aims to develop, evaluate and translate highly accelerated imaging sequences (each protocol under 5 minutes) for in-vivo knee Osteoarthritis applications on a standard clinical 3T scanner using novel compression sensing and parallel imaging strategies.The overarching objective of the study is to establish a non-invasive imaging biomarker based on the development of rapid relaxation mapping with compressed sensing (CS) that will be clinically useful for assessment of early Osteoarthritis. A total of 90 subjects including 30 patients with high risk of developing knee osteoarthritis (OA), 30 patients with mild OA and 30 healthy controls will be accrued.

Detailed description

Current noninvasive imaging methods to evaluate knee joints include plain radiographs, computed tomography (CT), and clinical morphological magnetic resonance imaging (MRI) of joint structures. These techniques can only detect later-stage, macroscopic joint structural abnormalities that are irreversible and not amenable to early therapy. This study aims to develop highly accelerated imaging sequences for ex-vivo knee OA applications on a standard clinical 3T scanner using novel CS and parallel imaging (PI) strategies.

Interventions

DEVICEPRISMA 3T MRI scanner (Siemens Medical Solutions)

A baseline MRI exam consisting of accelerated 3D-T1p, and T2, MRI will be performed. Longitudinal follow-up MRI exams (24 months) will be repeated on the same knee on all OA patients.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients in the HJD OA database, ages 40-75 with high risk of developing OA as defined by: (i) KL score of 0 (ii) Knee pain present in at least 1 knee (iii) Normal radiographs, (iv) At least one abnormal clinical MR finding such as prior knee injury, overweight or traumatic bone marrow edema lesions * Patients ages 40-75 with early OA as determined by KL scores 1-2 * Healthy controls in the HJD OA database (KL score 0, no knee pain, no meniscal or ligament tears)

Exclusion criteria

* Contraindications for MRIs (e.g. pacemakers, ferromagnetic vascular clips, metal implants, claustrophobia, etc). * Subjects with any joint disease (example: Rheumatoid or inflammatory arthritis) other than knee OA, corticosteroid injections within the previous 3 months, and history of avascular necrosis, Paget's disease of bone, Wilson's disease, gout, total knee replacement (or plan for replacement within next 24 months). * Major co-morbidities such as diabetes, mellitus, cancer, congestive heart failure and chronic infectious diseases. * Alignment interventions such as insoles and knee braces * Vulnerable patients will not be recruited for this study

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in T1ρ Relaxation TimeBaseline, Month 24MRI exam of accelerated 3D-T1p conducted on whole knee joint specimens to determine cartilage composition, measured as T1ρ relaxation time. T1ρ MRI relaxation times refer to the proteoglycan density within cartilage. Images taken at baseline and at Month 24.
Change From Baseline in T2 Relaxation TimeBaseline, Month 24MRI exam of accelerated T2 conducted on whole knee joint specimens to determine cartilage composition, measured as T2 relaxation time. T2 relaxation represents the time constant of the molecular motion of water in cartilage, which is influenced by the composition of collagen and specifically reflects changes to the extracellular matrix. Images taken at baseline and at Month 24.

Secondary

MeasureTime frameDescription
Change From Baseline in Western Ontario and McMaster University OA Index (WOMAC) ScoreBaseline, Month 24The WOMAC is a 33-item self assessment of how participants feel about their knee and how well they can perform usual activities. The questionnaire contains 4 separately scored subscales - Symptoms; Stiffness; Pain and Function; and Daily Living. The total score is a percentage score from 0 to 100; lower scores represent less pain, less stiffness, and better physical function; higher scores indicate greater pain, greater stiffness, and worse physical function. A decrease in scores indicates participants' health improved during the observational period.
Change From Baseline in Knee Injury and OA Outcomes Score (KOOS)Baseline, Month 24Knee-specific instrument, developed to assess patients' opinion about their knee and associated problems. The KOOS evaluates both short-term and long-term consequences of knee injury. It holds 42 items in 5 separately scored subscales - Pain; Other Symptoms; Function in daily living (ADL); Function in Sport and Recreation (Sport/Rec); and knee-related Quality of Life (QOL). The total score is a percentage score from 0 to 100; 0 represents extreme problems and 100 represents no problems. An increase in scores indicates participants' health improved during the observational period.
Change From Baseline in Physical Activity Scale for the Elderly (PASE) ScoresBaseline, 24 MonthsSelf-assessment of multiple domains of activity in older adults. Questions evaluate both occupational and non-occupational knee bending, squatting and stair climbing. Total scores range from 0 to 400 or above and are quantified based on frequency values and weights for these activities. Higher scores indicate higher levels of physical activity. An increase in scores indicates physical activity increased during the observational period.

Countries

United States

Participant flow

Participants by arm

ArmCount
High Risk for Osteoarthritis
High risk of developing knee OA has been defined by having knee pain but normal radiographs (Kellgren-Lawrence score 0 i.e. KL0) on both knees but at least one abnormal finding on clinical MR protocol such as overweight, prior knee injury (ligaments or menisci) or traumatic bone marrow edema lesions. PRISMA 3T MRI scanner (Siemens Medical Solutions): A baseline MRI exam consisting of accelerated 3D-T1p, and T2, MRI will be performed. Longitudinal follow-up MRI exams (24 months) will be repeated on the same knee on all OA patients.
6
Mild Osteoarthritis
PRISMA 3T MRI scanner (Siemens Medical Solutions): A baseline MRI exam consisting of accelerated 3D-T1p, and T2, MRI will be performed. Longitudinal follow-up MRI exams (24 months) will be repeated on the same knee on all OA patients.
3
Healthy Controls
Controls will be age/gender matched to patients within 2 years of age. PRISMA 3T MRI scanner (Siemens Medical Solutions): A baseline MRI exam consisting of accelerated 3D-T1p, and T2, MRI will be performed.
30
Total39

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up540

Baseline characteristics

CharacteristicHigh Risk for OsteoarthritisTotalHealthy ControlsMild Osteoarthritis
Age, Continuous62.3 years
STANDARD_DEVIATION 4.5
59.1 years
STANDARD_DEVIATION 8.2
57.9 years
STANDARD_DEVIATION 8.6
64.7 years
STANDARD_DEVIATION 5.7
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants4 Participants2 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants26 Participants20 Participants2 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants9 Participants8 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants1 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants12 Participants11 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants9 Participants7 Participants1 Participants
Race (NIH/OMB)
White
4 Participants16 Participants11 Participants1 Participants
Region of Enrollment
United States
6 participants39 participants30 participants3 participants
Sex: Female, Male
Female
4 Participants21 Participants15 Participants2 Participants
Sex: Female, Male
Male
2 Participants18 Participants15 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 30 / 30
other
Total, other adverse events
0 / 60 / 30 / 30
serious
Total, serious adverse events
0 / 60 / 30 / 30

Outcome results

Primary

Change From Baseline in T1ρ Relaxation Time

MRI exam of accelerated 3D-T1p conducted on whole knee joint specimens to determine cartilage composition, measured as T1ρ relaxation time. T1ρ MRI relaxation times refer to the proteoglycan density within cartilage. Images taken at baseline and at Month 24.

Time frame: Baseline, Month 24

ArmMeasureValue (MEAN)Dispersion
High Risk for OsteoarthritisChange From Baseline in T1ρ Relaxation Time2.1 millisecondsStandard Deviation 2.2
Mild OsteoarthritisChange From Baseline in T1ρ Relaxation Time13.3 millisecondsStandard Deviation 9.4
Primary

Change From Baseline in T2 Relaxation Time

MRI exam of accelerated T2 conducted on whole knee joint specimens to determine cartilage composition, measured as T2 relaxation time. T2 relaxation represents the time constant of the molecular motion of water in cartilage, which is influenced by the composition of collagen and specifically reflects changes to the extracellular matrix. Images taken at baseline and at Month 24.

Time frame: Baseline, Month 24

ArmMeasureValue (MEAN)Dispersion
High Risk for OsteoarthritisChange From Baseline in T2 Relaxation Time0.7 millisecondsStandard Deviation 6.3
Mild OsteoarthritisChange From Baseline in T2 Relaxation Time11 millisecondsStandard Deviation 7.8
Secondary

Change From Baseline in Knee Injury and OA Outcomes Score (KOOS)

Knee-specific instrument, developed to assess patients' opinion about their knee and associated problems. The KOOS evaluates both short-term and long-term consequences of knee injury. It holds 42 items in 5 separately scored subscales - Pain; Other Symptoms; Function in daily living (ADL); Function in Sport and Recreation (Sport/Rec); and knee-related Quality of Life (QOL). The total score is a percentage score from 0 to 100; 0 represents extreme problems and 100 represents no problems. An increase in scores indicates participants' health improved during the observational period.

Time frame: Baseline, Month 24

ArmMeasureValue (MEAN)Dispersion
High Risk for OsteoarthritisChange From Baseline in Knee Injury and OA Outcomes Score (KOOS)6 score on a scaleStandard Deviation 11.9
Mild OsteoarthritisChange From Baseline in Knee Injury and OA Outcomes Score (KOOS)6.2 score on a scaleStandard Deviation 4.5
Secondary

Change From Baseline in Physical Activity Scale for the Elderly (PASE) Scores

Self-assessment of multiple domains of activity in older adults. Questions evaluate both occupational and non-occupational knee bending, squatting and stair climbing. Total scores range from 0 to 400 or above and are quantified based on frequency values and weights for these activities. Higher scores indicate higher levels of physical activity. An increase in scores indicates physical activity increased during the observational period.

Time frame: Baseline, 24 Months

ArmMeasureValue (MEAN)Dispersion
High Risk for OsteoarthritisChange From Baseline in Physical Activity Scale for the Elderly (PASE) Scores3.8 score on a scaleStandard Deviation 10.1
Mild OsteoarthritisChange From Baseline in Physical Activity Scale for the Elderly (PASE) Scores3.2 score on a scaleStandard Deviation 4.5
Secondary

Change From Baseline in Western Ontario and McMaster University OA Index (WOMAC) Score

The WOMAC is a 33-item self assessment of how participants feel about their knee and how well they can perform usual activities. The questionnaire contains 4 separately scored subscales - Symptoms; Stiffness; Pain and Function; and Daily Living. The total score is a percentage score from 0 to 100; lower scores represent less pain, less stiffness, and better physical function; higher scores indicate greater pain, greater stiffness, and worse physical function. A decrease in scores indicates participants' health improved during the observational period.

Time frame: Baseline, Month 24

ArmMeasureValue (MEAN)Dispersion
High Risk for OsteoarthritisChange From Baseline in Western Ontario and McMaster University OA Index (WOMAC) Score5.4 score on a scaleStandard Deviation 8.6
Mild OsteoarthritisChange From Baseline in Western Ontario and McMaster University OA Index (WOMAC) Score2.5 score on a scaleStandard Deviation 4.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026